A NEW PROSPECT FOR WEIGHT REGULATION?

Researchers are excitedly examining retatrutide, a promising medication developed by Eli Lilly, as a potential step in weight loss . Unlike many earlier approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, chemicals that impact appetite and blood glucose balance. Ini